The role of tumor necrosis factor and nitric oxide in the acute cardiovascular response to endotoxin

被引:28
作者
Fahey, TJ
Yoshioka, T
Shires, T
Fantini, GA
机构
[1] NEW YORK HOSP,CORNELL MED CTR,DEPT SURG,NEW YORK,NY 10021
[2] NEW YORK HOSP,CORNELL MED CTR,DIV VASC SURG,NEW YORK,NY 10021
关键词
D O I
10.1097/00000658-199601000-00009
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective This study was designed to examine the differential effects of tumor necrosis factor (TNF) and nitric oxide on the acute cardiovascular changes that occur in response to endotoxemia. Summary Background Data Recent studies have suggested that some, if not all, of the cardiovascular effects of TNF are mediated through release of nitric oxide. However, the mechanisms through which TNF and nitric oxide induce hypotension and shock in vivo in response to systemic endotoxemia remain poorly characterized, despite current interest in the use of nitric oxide antagonists to ameliorate septic shock. Methods A reproducible model of endotoxemia was established in adult Sprague-Dawley rats. The acute cardiovascular changes that occur after bolus infusion of endotoxin was then determined in rats treated with either TNF antibody, N-methyl arginine, or both. Results Inhibition of either TNF or nitric oxide restores mean arterial blood pressure to normal after endotoxemia (p < 0.05). However, nitric oxide exerts its effects principally on the peripheral vasculature, whereas TNF appears to act on the myocardium. A combination of TNF antiserum pretreatment and N-methyl arginine administration is necessary to return mean arterial blood pressure to normal 60 minutes after endotoxin infusion. Conclusion Tumor necrosis factor and nitric oxide mediate the acute cardiovascular effects of endotoxemia through distinct mechanisms. Nitric oxide is released as a result of both TNF-dependent and TNF-independent mechanisms, whereas the cardiovascular effects of TNF are only partially mediated through nitric oxide.
引用
收藏
页码:63 / 69
页数:7
相关论文
共 22 条
[1]  
ANDERSON BO, 1991, SURG GYNECOL OBSTET, V172, P415
[2]  
BEUTLER BA, 1985, J IMMUNOL, V135, P3972
[3]   ADVANCED GLYCOSYLATION PRODUCTS QUENCH NITRIC-OXIDE AND MEDIATE DEFECTIVE ENDOTHELIUM-DEPENDENT VASODILATATION IN EXPERIMENTAL DIABETES [J].
BUCALA, R ;
TRACEY, KJ ;
CERAMI, A .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (02) :432-438
[4]   TUMOR-NECROSIS-FACTOR AND CARDIAC-FUNCTION [J].
DEMEULES, JE ;
PIGULA, FA ;
MUELLER, M ;
RAYMOND, SJ ;
GAMELLI, RL .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1992, 32 (06) :686-692
[5]  
Fahey T J 3rd, 1990, Cytokine, V2, P92, DOI 10.1016/1043-4666(90)90002-B
[6]   IBUPROFEN IN CANINE ENDOTOXIN-SHOCK [J].
JACOBS, ER ;
SOULSBY, ME ;
BONE, RC ;
WILSON, FJ ;
HILLER, FC .
JOURNAL OF CLINICAL INVESTIGATION, 1982, 70 (03) :536-541
[7]   REVERSAL OF ENDOTOXIN-MEDIATED SHOCK BY NG-METHYL-L-ARGININE, AN INHIBITOR OF NITRIC-OXIDE SYNTHESIS [J].
KILBOURN, RG ;
JUBRAN, A ;
GROSS, SS ;
GRIFFITH, OW ;
LEVI, R ;
ADAMS, J ;
LODATO, RF .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 172 (03) :1132-1138
[8]   NG-METHYL-L-ARGININE INHIBITS TUMOR NECROSIS FACTOR-INDUCED HYPOTENSION - IMPLICATIONS FOR THE INVOLVEMENT OF NITRIC-OXIDE [J].
KILBOURN, RG ;
GROSS, SS ;
JUBRAN, A ;
ADAMS, J ;
GRIFFITH, OW ;
LEVI, R ;
LODATO, RF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (09) :3629-3632
[9]  
KLABUNDE RE, 1992, RES COMMUN CHEM PATH, V78, P57
[10]   PARTICIPATION OF TUMOR NECROSIS FACTOR IN THE MEDIATION OF GRAM-NEGATIVE BACTERIAL LIPOPOLYSACCHARIDE-INDUCED INJURY IN RABBITS [J].
MATHISON, JC ;
WOLFSON, E ;
ULEVITCH, RJ .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (06) :1925-1937